CTKB
NASDAQ
$4.58
Cytek BioSciences Inc (CTKB)
Cytek Biosciences Inc (CTKB) is a pioneering force in multi-parameter flow cytometry, delivering innovative cell analysis solutions that advance research in immunology, cancer diagnostics, and drug development. The company leverages its proprietary technologies to meet the growing demand for precision in cellular analytics, positioning itself as a key player in the biotechnology sector. With a robust product portfolio and a commitment to exceptional customer support, Cytek is well-equipped to drive transformative discoveries, ultimately enhancing healthcare outcomes and addressing critical challenges in the life sciences.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $5.69 (+24.24%)
Market Cap
$601M
Free Cash Flow Yield
-2.11%
Beta (5Y)
1.27
Price Chart
Valuation
Market Cap$601M
Forward P/E370.37
P/S2.94
P/B1.82
Profitability
Total Revenue (TTM)$204M
Gross Profit (TTM)$106M
EBITDA-$36M
Profit Margin-42.7%
Operating Margin-41.8%
EPS-$0.58
Financial Health
Free Cash Flow Yield-2.11%
Growth & Risk
Revenue 5Y CAGR+11.76%
Beta (5Y)1.27
Sharpe Ratio0.79